The Effect of Oestrone on the Incidence of Mammary Carcinoma and Adenoma in C3Hf Breeders after Late Ovariectomy
1960

The Effect of Oestrone on Mammary Tumors in Mice

Sample size: 53 publication Evidence: moderate

Author Information

Author(s): B. D. Pullinger

Primary Institution: Royal Beatson Memorial Hospital, Glasgow

Hypothesis

Does oestrone treatment after ovariectomy affect the incidence of mammary carcinoma and adenoma in C3Hf mice?

Conclusion

Oestrone treatment after ovariectomy significantly increased the incidence of mammary carcinoma and adenoma in C3Hf mice.

Supporting Evidence

  • 2 out of 30 mice treated with 5 µg of oestrone developed mammary carcinoma.
  • 6 out of 23 mice treated with 10 µg of oestrone developed mammary carcinoma.
  • 12 out of 18 mice treated with 5 µg of oestrone bore adenomatous nodules.
  • 14 out of 14 mice treated with 10 µg of oestrone bore adenomatous nodules.

Takeaway

When female mice had their ovaries removed and then received a hormone called oestrone, more of them developed breast tumors.

Methodology

C3Hf mice were ovariectomized and treated with oestrone weekly for 30 weeks, with subsequent monitoring for tumor development.

Potential Biases

Potential bias in the selection of mice and the method of treatment application.

Limitations

The study did not test higher doses of oestrone due to observed health issues in treated mice.

Participant Demographics

C3Hf mice, specifically surplus breeders aged 9 to 11 months.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication